Low-molecular-weight heparin administration in patients with end-stage renal disease--a comment.
Lile
J
J
Department of Pharmacy, MidMichigan Health, Midland 48670, USA.
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001803:Blood Transfusion; D017984:Enoxaparin / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000097:blood / Q000378:metabolism* / Q000628:therapy; D006435:Renal Dialysis
D000925:Anticoagulants; D017984:Enoxaparin